Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

The community will rally behind Ali Readel this May, as a fundraiser to help offset her medical bills after her fight with ...

Pelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves ...

This is the 11th year that Little Eric’s Foundation participated, as an organization, in Cycle for Survival in New York City.

Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...

A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient ...

Memorial Hospital for Cancer and Allied Diseases and Memorial Sloan Kettering Cancer Center have jointly developed new nonsteroid selective androgen receptor modulators (SARMs) and radiolabeled ...

Gary A. Ulaner, M.D., Ph.D., F.A.C.N.M. is the director of molecular imaging and therapy at Hoag Family Cancer Institute and ...

The community has a GoFundMe campaign that is raising money for the cancer treatment for longtime Brookfield firefighter ...

Fox News’ Kat Timpf d a health update with fans after surgery for a shocking cancer diagnosis. The 36-year-old comedian and Fox News contributor underwent a double […] ...